Given the lack of patient-based study for CS related DM, current general recommendations have been borrowed from type 2 DM patients with metformin and GLP1 analogues as first line choices, thanks respectively to insulin sensitizing properties and to CV protection and anorectic effects. The gene discussed is GCG; the disease is diabetes mellitus.